Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. August 2019 16:07 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Second Quarter 2019 Financial Results

SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives, including immunotherapies, today reported financial...
07. August 2019 07:30 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference

SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
29. Juli 2019 07:00 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin

Data from second part of successful Phase 2 STRIVE trial further substantiate the efficacy, safety and tolerability of once-weekly rezafungin for first-line treatment of invasive Candida infections ...
09. Mai 2019 16:13 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports First Quarter 2019 Financial Results

SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
03. April 2019 16:04 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at the 18th Annual Needham Healthcare Conference

SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
28. Februar 2019 16:24 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2018 Financial Results

SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
08. November 2018 17:23 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Third Quarter 2018 Financial Results

SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
24. September 2018 16:05 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at Two Upcoming Investor Conferences

SAN DIEGO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
08. August 2018 16:30 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Second Quarter 2018 Financial Results

SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
21. Mai 2018 07:30 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Offering of Common Stock and Warrants

SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has...

Nächste Seite